What is the dosing of carbonic anhydrase inhibitors?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

What is the dosing of carbonic anhydrase inhibitors?

Explanation:
Topical carbonic anhydrase inhibitors for glaucoma are used to lower IOP by reducing aqueous humor production, and their dosing is typically adjusted based on how they’re being used in a regimen. When these agents are added to other IOP-lowering medications, twice daily dosing is common to maintain effectiveness while keeping patient tolerability and adherence in mind. The FDA labeling for these drugs, however, often specifies three times daily dosing to achieve the maximum IOP reduction. So in practice, the recommended approach reflects both contexts: twice daily when used as adjunct therapy, and three times daily per FDA labeling.

Topical carbonic anhydrase inhibitors for glaucoma are used to lower IOP by reducing aqueous humor production, and their dosing is typically adjusted based on how they’re being used in a regimen. When these agents are added to other IOP-lowering medications, twice daily dosing is common to maintain effectiveness while keeping patient tolerability and adherence in mind. The FDA labeling for these drugs, however, often specifies three times daily dosing to achieve the maximum IOP reduction. So in practice, the recommended approach reflects both contexts: twice daily when used as adjunct therapy, and three times daily per FDA labeling.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy